In my opinion ACR is the Axiron show - that's why the sp fell so much when the FDA threatened Axiron sales. The other products are not likely to show much revenue. Also in my view the "pipeline" should be treated as worthless because management refuses to hold themselves accountable to a delivery schedule - actually worse than worthless because its a cash drain. You should only buy in if you believe Axiron sales will rise.
Add to My Watchlist
What is My Watchlist?
